These results indicate that EGPI-1 can be used as an excellent lead compound to develop new anti-cancer drugs targeting eIF4E-eIF4G interface, and also as a chemical genetic probe to study the mechanism of eIF4E in biological processes and human diseases (188). The gene discussed is EIF4E; the disease is cancer.